Evidence map›Paper›PMID 34976171›Full record

ArticleJournal of Cancer2022

Ago-RIP Sequencing Identifies New MicroRNA-449a-5p Target Genes Increasing Sorafenib Efficacy in Hepatocellular Carcinoma.

Thea Reinkens, Amelie Stalke, Nicole Huge, Beate Vajen, Marlies Eilers, Vera Schäffer, Oliver Dittrich-Breiholz, Brigitte Schlegelberger, Thomas Illig, Britta Skawran

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Thea ReinkensDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Amelie StalkeDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Nicole HugeDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Beate VajenDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Marlies EilersDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Vera SchäfferDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Oliver Dittrich-BreiholzResearch Core Unit Genomics, Hannover Medical School, Hannover, Germany.
Brigitte SchlegelbergerDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Thomas IlligDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Britta SkawranDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ago-RIP sequencingdrug resistanceLiver cancermicroRNA combination therapymicroRNA target genesmulti-tyrosine kinase inhibitor

Identifiers

PMID34976171
PMCPMC8692677
OpenAlexW4200378164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.